Mitochondrial DNA heteroplasmy in disease and targeted nuclease‐based therapeutic approaches
Nadee Nissanka(University of Miami), Carlos T. Moraes(University of Miami)
Cited by 118
Related Papers
MELAS: Clinical features, biochemistry, and molecular genetics
|Annals of Neurology|1992|508
Mitochondrial <scp>DNA</scp> damage and reactive oxygen species in neurodegenerative disease
|FEBS Letters|2017|441
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306
MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation
|Nature Medicine|2018|285
Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA
|Neuromuscular Disorders|1993|238